Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
CA 2489469 C · Owner: Gold, David V. · Inventors: Gold, David V.; Goldenberg, David M.; Hansen, Hans
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to monovalent and multivalent monospecific antibodies , and to monovalent and multivalent multispecific antibodies. One embodiment of these antibodies has one or more identical binding sites where each binding site binds with a target antigen or an epitope on a target antigen. Another embodiment of these antibodies has two or more binding sites where these binding sites have affinity towards different epitopes on a target antigen or different target antigens, or have affinity towards a target antigen and a hapten. The present invention further relates to recombinant vectors useful for the expression of these functionalantibodies in a host. More specifically the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 16, 2003 and granted March 22, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 16, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 16, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.